AtheroGenics

Industry · 2 registered clinical trials.

Status	Trial	Phase	Started
Unknown	ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study Diabetes	Phase 2 / Phase 3	2007-08-01
Unknown	ARISE - Aggressive Reduction of Inflammation Stops Events Atherosclerosis, Coronary Artery Disease, Myocardial Infarction	Phase 3	2003-06-01